New patent for Astrazeneca Ab drug BYDUREON BCISE

October 13, 2020 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for BYDUREON+BCISE Bydureon Bcise is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-one…

The post New patent for Astrazeneca Ab drug BYDUREON BCISE appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.